1. Home
  2. ATPC vs CLDI Comparison

ATPC vs CLDI Comparison

Compare ATPC & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agape ATP Corporation

ATPC

Agape ATP Corporation

HOLD

Current Price

$2.45

Market Cap

2.2M

Sector

Health Care

ML Signal

HOLD

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

HOLD

Current Price

$0.10

Market Cap

2.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATPC
CLDI
Founded
2016
2014
Country
Malaysia
United States
Employees
N/A
29
Industry
Medical/Nursing Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.4M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
ATPC
CLDI
Price
$2.45
$0.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.5M
2.6M
Earning Date
04-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,524,262.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
15.23
N/A
52 Week Low
$0.05
$0.10
52 Week High
$8.50
$7.32

Technical Indicators

Market Signals
Indicator
ATPC
CLDI
Relative Strength Index (RSI) 44.43 27.44
Support Level $1.93 N/A
Resistance Level $2.55 $0.18
Average True Range (ATR) 0.35 0.01
MACD -0.04 -0.00
Stochastic Oscillator 1.41 0.91

Price Performance

Historical Comparison
ATPC
CLDI

About ATPC Agape ATP Corporation

Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. Its technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations. Its product candidates include The RedTail for Metastatic Solid Tumors, CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-101 (NeuroNova) for Newly Diagnosed High Grade Glioma.

Share on Social Networks: